נוטרי כורכומין - כורכומין ליפוזומלי

[1] Shep, D., Khanwelkar, C., Et al. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials 20, 214 (2019). Doi: /10.1186/s13063-019-3327-2.
[2] Singhal S, Hasan N, Et al. Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials. 2021 Jan 30;22(1):105. doi: 10.1186/s13063-021-05053-7. PMID: 33516238; PMCID: PMC7847013.
[3] Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25. doi: 10.1007/978-0-387-46401-5_3. PMID: 17569207.
[4] El-Saadony MT, Yang T, Et al. Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review. Front Nutr. 2023 Jan 10;9:1040259. doi: 10.3389/fnut.2022.1040259. PMID: 36712505; PMCID: PMC9881416.
[5] Dehzad MJ, Ghalandari H, Et al. Effects of curcumin/turmeric supplementation on lipid profile: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Complement Ther Med. 2023 Aug;75:102955. doi: 10.1016/j.ctim.2023.102955. Epub 2023 May 23. PMID: 37230418.
[6] Zhang DW, Et al. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053. doi: 10.1155/2013/636053. Epub 2013 Nov 24. PMID: 24348712; PMCID: PMC3857752.
[7] Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol. 2013 Dec 28;19(48):9256-70. doi: 10.3748/wjg.v19.i48.9256. PMID: 24409053; PMCID: PMC3882399.
[8] Radomska-Leśniewska DM, Et al. Therapeutic potential of curcumin in eye diseases. Cent Eur J Immunol. 2019;44(2):181-189. doi: 10.5114/ceji.2019.87070. Epub 2019 Jul 30. PMID: 31530988; PMCID: PMC6745545.
[9] Ghosh SS, Gehr TW, Ghosh S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules. 2014 Dec 2;19(12):20139-56. doi: 10.3390/molecules191220139. PMID: 25474287; PMCID: PMC6271001.
[10] Dr. Yogesh A. Dound, Dr. Ramesh Jayaraman. Relative Oral Bioavailability Study of Liposomal Curcumin. The Indian Practitioner. 73, 10 (Oct. 2020), 21-25.
[11] Bertoncini-Silva C, Vlad A, Et al. Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment. Antioxidants (Basel). 2024 Mar 8;13(3):331. doi: 10.3390/antiox13030331. PMID: 38539864; PMCID: PMC10967568.
[12] Bulboacă AE, Boarescu PM, Et al. Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus. Int J Nanomedicine. 2019 Nov 18;14:8961-8972. doi: 10.2147/IJN.S226790. PMID: 31819412; PMCID: PMC6873975.
[13] Shoba G, Joy D, Joseph T, Et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6. doi: 10.1055/s-2006-957450. PMID: 9619120.